✦ LIBER ✦

Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases

✍ Scribed by Johanna Liebl; Vladimir Krystof; György Vereb; Lili Takács; Miroslav Strnad; Paul Pechan; Libor Havlicek; Marek Zatloukal; Robert Fürst; Angelika M. Vollmar; Stefan Zahler

Book ID: 106337878
Publisher: Springer
Year: 2011
Tongue: English
Weight: 658 KB
Volume: 14
Category: Article
ISSN: 0969-6970
DOI: 10.1007/s10456-011-9212-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-angiogenic potential of small molec

Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro

✍ Stefan Zahler; Johanna Liebl; Robert Fürst; Angelika M. Vollmar 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 609 KB

2-Aminoquinazoline Inhibitors of Cyclin-

2-Aminoquinazoline Inhibitors of Cyclin-Dependent Kinases.

✍ Yadagiri Bathini; Inderjit Singh; Patricia J. Harvey; Paul R. Keller; Rajeshwar 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Small Molecules as Inhibitors of Cyclin-

Small Molecules as Inhibitors of Cyclin-Dependent Kinases

✍ Axel Huwe; Ralph Mazitschek; Athanassios Giannis 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 51 KB 👁 2 views

Small Molecules as Inhibitors of Cyclin-

Small Molecules as Inhibitors of Cyclin-Dependent Kinases

✍ Axel Huwe; Ralph Mazitschek; Athanassios Giannis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

β-Carbolines as specific inhibitors of c

β-Carbolines as specific inhibitors of cyclin-Dependent kinases

✍ Yongcheng Song; Jian Wang; Su Fern Teng; Djohan Kesuma; Yu Deng; Jinao Duan; Jer 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Inhibitors of cyclin-dependent kinase an

Inhibitors of cyclin-dependent kinase and cancer

✍ J. R. Biggs; A. S. Kraft 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 621 KB

Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 an